Back to company

LÆGEHUSET I NØRREGADE. HERNING. ApS: Financial statements 2024

CVR: 32086012

LÆGEHUSET I NØRREGADE. HERNING. ApS (CVR 32086012) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 372,809 and a net result of DKK 260,866 compared with DKK 1,292,606 the year before. That is a decrease of 7.4% compared with the year before. Equity amounted to DKK 7,080,491. The solvency ratio was 73.4%.

Gross Profit
372,809 kr.
Profit/Loss
260,866 kr.
Equity
7,080,491 kr.
Total Assets
9,652,587 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-373 t.261 t.7.1 mio.0
2023-403 t.1.3 mio.6.8 mio.0
2022-418 t.284 t.5.5 mio.0
2021-369 t.244 t.5.2 mio.0
2020--698 t.-650 t.5 mio.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is LÆGEHUSET I NØRREGADE. HERNING. ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

LÆGEHUSET I NØRREGADE. HERNING. ApS: The 2023 annual report is outApr 4, 2024

LÆGEHUSET I NØRREGADE. HERNING. ApS has published its annual report for 2023. Gross profit came to DKK 402,722, and the net result was DKK 1,292,606.

Karen Lundsgaard Hansen joins the board of LÆGEHUSET I NØRREGADE. HERNING. ApSApr 3, 2024

As of April 3, 2024, Karen Lundsgaard Hansen has joined the board of directors of LÆGEHUSET I NØRREGADE. HERNING. ApS.

Peter Johansen joins the board of LÆGEHUSET I NØRREGADE. HERNING. ApSApr 3, 2024

As of April 3, 2024, Peter Johansen has joined the board of directors of LÆGEHUSET I NØRREGADE. HERNING. ApS.

Lasse Bjørn Spliid joins the board of LÆGEHUSET I NØRREGADE. HERNING. ApSApr 3, 2024

As of April 3, 2024, Lasse Bjørn Spliid has joined the board of directors of LÆGEHUSET I NØRREGADE. HERNING. ApS.

Lisbeth Trans leaves the board of LÆGEHUSET I NØRREGADE. HERNING. ApSApr 3, 2024

As of April 3, 2024, Lisbeth Trans has left the board of directors of LÆGEHUSET I NØRREGADE. HERNING. ApS.

Rasmus Bloch Schmidt leaves the board of LÆGEHUSET I NØRREGADE. HERNING. ApSApr 3, 2024

As of April 3, 2024, Rasmus Bloch Schmidt has left the board of directors of LÆGEHUSET I NØRREGADE. HERNING. ApS.

Kate Meedom Klostergaard leaves the board of LÆGEHUSET I NØRREGADE. HERNING. ApSApr 3, 2024

As of April 3, 2024, Kate Meedom Klostergaard has left the board of directors of LÆGEHUSET I NØRREGADE. HERNING. ApS.

Lasse Bjørn Spliid joins LÆGEHUSET I NØRREGADE. HERNING. ApS as directorApr 3, 2024

As of April 3, 2024, Lasse Bjørn Spliid is registered as director of LÆGEHUSET I NØRREGADE. HERNING. ApS.

Kate Meedom Klostergaard steps down as director of LÆGEHUSET I NØRREGADE. HERNING. ApSApr 3, 2024

As of April 3, 2024, Kate Meedom Klostergaard has stepped down as director of LÆGEHUSET I NØRREGADE. HERNING. ApS.

About LÆGEHUSET I NØRREGADE. HERNING. ApS

LÆGEHUSET I NØRREGADE. HERNING. ApS is a Danish company of the type Anpartsselskab based in Herning, founded in 1974. The company is registered under the industry Udlejning af erhvervsejendomme. The management consists of Karen Inger Sahlholdt. The company's owners include Karen Lundsgaard Hansen, Lisbeth Trans and Karen Inger Sahlholdt. The company has 0 employees. In 2025, the company reported a gross profit of DKK 314,779 and a net result of DKK 219,652 compared with DKK 260,866 the year before. Equity amounted to DKK 7,300,144.